BioAge Labs, Inc. ( (BIOA) ) has released its Q3 earnings. Here is a breakdown of the information BioAge Labs, Inc. presented ...

Initiated Phase 2 STRIDES trial of azelaprag in combination with tirzepatide for obesityCompleted $238.3 million initial public offering and ...

NEW YORK (AP) — The following is a list of initial public offerings planned for the coming week. Sources include IPO ETF manager Renaissance Capital, and SEC filings. Week of Nov. 4 Brazil ...

Not only are deals going off at higher valuations than the companies initially anticipated, but the prices have been popping after the stocks began trading in the public markets. Observers are hoping ...

The online photo and video editing platform increased its value by nearly $10bn from$39.57bn ($US26bn) to $48.7bn ($US32bn) after the secondary sale, which allowed ...

BioAge Labs has completed its upsized initial public offering (IPO), raising $198 million after increasing the number of ...

announced today the closing of its initial public offering of 1,300,000 ordinary shares at a public offering price of US$4.00 per share. The ordinary shares commenced trading on the Nasdaq Global ...

Celebrating his company’s upsized initial public offering (IPO), Septerna CEO Jeffrey Finer rang the opening bell on the Nasdaq stock exchange on Friday morning in New York, in the latest sign ...

Biotech firm Septerna on Thursday said it raised $288 million in its initial public offering that has been upsized twice ... Robust debuts by drug developers Bicara Therapeutics , MBX Biosciences, ...

(Reuters) -Biotech firm Septerna on Thursday said it raised $288 million in its initial public offering that has been upsized twice ... MBX Biosciences, BioAge Labs and Upstream Bio are also ...